Literature DB >> 26806562

Incorrect inference in prevalence trend analysis due to misuse of the odds ratio.

Scott Mcclintock1, Zhen-Qiang Ma2, Randall H Rieger3.   

Abstract

Because public health agencies usually monitor health outcomes over time for surveillance, program evaluation, and policy decisions, a correct health outcome trend analysis is vital. If the analysis is done incorrectly and/or results are misinterpreted, a faulty trend analysis could jeopardize key aspects of public health initiatives such as program planning, implementations, policy development, and clinical decision making. It is essential then that accurate health outcome trend analysis be implemented in any data-driven decision-making process. Unfortunately, there continues to be common statistical mistakes in prevalence trend analysis. In this article, using recently published results from the Pediatric Nutrition Surveillance System, we will show the effect that an incorrect trend analysis and subsequent interpretation of results can have. We will also propose more appropriate statistical processes, such as the log-binomial model, for these situations.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Education; Epidemiologic methods; Modeling; Obesity; Statistics

Mesh:

Year:  2016        PMID: 26806562     DOI: 10.1016/j.annepidem.2015.12.009

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  2 in total

1.  Treatment gap, help-seeking, stigma and magnitude of alcohol use disorder in rural Ethiopia.

Authors:  Selamawit Zewdu; Charlotte Hanlon; Abebaw Fekadu; Girmay Medhin; Solomon Teferra
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-01-18

2.  Perceived Stress During the First Wave of COVID-19 Outbreak: Results From Nationwide Cross-Sectional Study in Estonia.

Authors:  Rainer Reile; Lembe Kullamaa; Reeli Hallik; Kaire Innos; Maarja Kukk; Kaia Laidra; Eha Nurk; Merili Tamson; Sigrid Vorobjov
Journal:  Front Public Health       Date:  2021-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.